Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells

2014 ◽  
Vol 354 (1) ◽  
pp. 172-180 ◽  
Author(s):  
He Ren ◽  
Lingling Jia ◽  
Tiansuo Zhao ◽  
Huan Zhang ◽  
Jing Chen ◽  
...  
PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0126686 ◽  
Author(s):  
Alisha M. Mendonsa ◽  
Madeleine C. Chalfant ◽  
Lee D. Gorden ◽  
Michael N. VanSaun

2007 ◽  
Vol 170 (2) ◽  
pp. 469-477 ◽  
Author(s):  
Feng Wang ◽  
Shu Shun Li ◽  
Ralf Segersvärd ◽  
Lisa Strömmer ◽  
Karl-Gösta Sundqvist ◽  
...  

2018 ◽  
Author(s):  
Yi-Ting Chen ◽  
Tso-Wen Wang ◽  
Tsung-Hao Chang ◽  
Teng-Po Hsu ◽  
Jhih-Ying Chi ◽  
...  

ABSTRACTPancreatic cancer is refractory and characterized by extensively surrounding- and intra-tumor fibrotic reactions that are contributed by activated pancreatic stellate cells (PSCs). Activation of PSCs plays a pivotal role for developing fibrotic reactions to affect themselves or pancreatic cancer cells (PCCs). In the current study, we demonstrated that hepatoma-derived growth factor (HDGF) was secreted from transforming growth factor-β1 (TGF-β1)-treated PSCs. We found that HDGF contributed to anti-apoptosis of PSCs and led to synthesis and depositions of extracellular matrix proteins for stabilizing PSCs/PCCs tumor foci. CCAAT/enhancer binding protein δ (CEBPD) responds to TGF-β1 through a reciprocal loop regulation and further activated hypoxia inducible factor-1α (HIF-1α) contributed to up-regulation ofHDGFgene. It agrees with the observation that severe stromal growth positively correlated with stromal HDGF and CEBPD in pancreatic cancer specimens. Collectively, the identification of TGF-β1-activated CEBPD/HIF-1α/HDGF axis provides new insights for the novel discoveries of HDGF in anti-apoptosis and pro-fibrosis of PSCs and outgrowth of pancreatic cancer cells.


2012 ◽  
Author(s):  
Alisha Mendonsa ◽  
Madeleine Chalfant ◽  
Nagaraj Nagathihalli ◽  
Nipun Merchant ◽  
Lee Gorden ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document